ArticleJournal of acquired immune deficiency syndromes (1999)2026
Brief Report: Availability of Substance Use Services at US HIV Care Facilities by Urbanicity.
Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEnsuring access to substance use-related services (SUS)-including substance use disorder treatment, medication-assisted treatment, and syringe services-could improve the social determinants of health of people with HIV (PWH) with substance use disorder and reduce HIV transmission risk. We describe access to SUS at HIV care facilities by urbanicity.
methodsWe analyzed Medical Monitoring Project 2021 data from 514 HIV care facilities and linked these data to Medical Monitoring Project respondent data from 2019. We calculated weighted percentages of facility and patient characteristics by urbanicity of HIV care site: counties of ≥1,000,000 people [large metro (LM)]; 250,000-1,000,000 people (medium metro); or <250,000 people [small metro/nonmetro (SMN)]. We calculated and reported weighted percentages for service availability by urbanicity.
resultsAn estimated 72.1%, 15.2%, and 12.7% of facilities were in large, medium, and SMN counties, respectively. The percentage of PWH attending facilities with substance use disorder treatment available onsite was lower in SMN counties than LM counties (22.5% vs. 34.9%). The percentage attending facilities with no medication-assisted treatment availability either onsite or through referral was higher in SMN counties than LM counties (49.4% vs. 28.0%). A higher percentage of PWH attended facilities with no syringe services onsite or through referral in SMN areas than in LM areas (57.8% vs 48.3%).
conclusionsAccess to key SUS was lower among patients receiving HIV care in SMN counties. Improving access to SUS, especially for PWH attending HIV care facilities in small/nonmetro counties, may help support national goals for ending HIV and improving PWH's social determinants of health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.